Le Lézard

Oncolytics Biotech® Announces Promising Efficacy and Translational Data Supporting Pelareorep in KRAS-Mutant Metastatic Colorectal Cancer

Oncolytics Biotech® Inc. ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announced clinical and translational findings supporting the development ...
Le Lézard

Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction

STAAR Surgical Company , the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICLtm) for vision correction, today reported that independent industry analysts have ...

ImmunityBio Reports Strong Long-Term Survival Data For Anktiva In Bladder Cancer Study

ImmunityBio says Anktiva plus BCG showed durable survival and bladder preservation at 36 months in BCG-unresponsive bladder ...

Marcia Marcus’s Art Was Ignored for Decades. She Kept Painting Anyway.

And she did. For the next seven decades, Marcus lived in Manhattan, and she painted. She painted as she raised her two ...

Sutro Biopharma Announces First Cohort of Patients Dosed in Phase 1 Trial of STRO-004, a Next-Generation Tissue Factor ADC, in TF-Expressing Solid Tumors

Detailed price information for Sutro Biopharma Inc (STRO-Q) from The Globe and Mail including charting and trades.